IndiaTickerLatest filing: Certificate under SEBI (Depositories and Participants) Regulations, 2018 - AstraZeneca Pharma India Limited
ObservedCompany dossier
AstraZeneca Pharma
NSE:ASTRAZEN · ISIN INE203A01020
- Close
- ₹8,185 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
AstraZeneca Pharma
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹440.3 Cr · PAT ₹30.9 Cr.
Exchange XBRLLatest ownership: promoter group 75.00% and public 25.00% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - AstraZeneca Pharma India Limited
NSE · exchange filing
Observed
Source filing AstraZeneca Pharma India Ltd - 506820 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
BSE · exchange filing
Observed
Source filing Action(s) initiated or orders passed - AstraZeneca Pharma India Limited
NSE · exchange filing
Observed
Source filing AstraZeneca Pharma India Ltd - 506820 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
BSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹440.3 Cr
- Profit after tax
- ₹30.9 Cr
- EPS
- ₹12.34
Observed NSE structured filing · Non-Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 75.00%
- Public
- 25.00%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL